Noninvasive prenatal testing for aneuploidy–ready for prime time?
about
Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issuesGestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.Acceptability of prenatal testing and termination of pregnancy in Pakistan.Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service.Beyond Trisomy 21: Additional Chromosomal Anomalies Detected through Routine Aneuploidy Screening.Non-invasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA.Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.Non-Invasive Screening Tools for Down's Syndrome: A Review.Effects of sample processing and storage on the integrity of cell-free miRNAs in maternal plasma.Prenatal screening methods for aneuploidiesWill the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice?Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies.Factors affecting the clinical use of non-invasive prenatal testing: a mixed methods systematic review.Non-invasive prenatal diagnosis: progress and potential.Screening for Down syndrome.Detection of fetal structural anomalies in a basic first-trimester screening program for aneuploidy.Genomic futures of prenatal screening: ethical reflection.Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNAMicroarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use?Women's Experiences of Publicly Funded Non-Invasive Prenatal Testing in Ontario, Canada: Considerations for Health Technology Policy-Making.Non-invasive prenatal testing: UK genetic counselors' experiences and perspectives.Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy.Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.Informed decision-making about prenatal cfDNA screening: An assessment of written materials.Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non-invasive prenatal testing?Cell-free fetal DNA: the new tool in fetal medicineShould cell-free fetal DNA be included in first trimester screening (FTS) for common trisomy? A possible scenario on 6697 women screened over 10 years.The price of performance: a cost and performance analysis of the implementation of cell-free fetal DNA testing for Down syndrome in Ontario, Canada.Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users' views and likely uptake.Women's perspectives on the ethical implications of non-invasive prenatal testing: a qualitative analysis to inform health policy decisions.The impact of introducing combined first-trimester trisomy 21 screening in the French population.Women’s and health professionals’ preferences for prenatal tests for Down syndrome: a discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive testsTermination for fetal anomaly: Are women in England given a choice of method?What Is “NIPT”? Divergent Characterizations of Noninvasive Prenatal Testing StrategiesWomen’s experience of care when undergoing termination of pregnancy for fetal anomaly in England
P2860
Q26764809-3548BA94-C3E6-4CDC-AD60-B8AC0EF13411Q34336915-0D77AC2F-F1C0-4CBA-A44F-72E22B821BF7Q34480344-1F8FE1A2-F9C1-4C63-8F87-701B313F0308Q34862292-0E9FC0A9-749C-4E09-8354-B07E53684D30Q35142853-CBB6F0F8-738F-4BBC-9185-4007A7584694Q35667283-D770CCCA-8CA5-4710-9D72-413B8B8CAC91Q36079264-F64A36BD-0BC7-47D7-8F7D-68D87F03DF8DQ36184534-555AE834-3FED-446F-BBFC-C7AD699CB11CQ36335133-D8B6F5A1-0F60-43BF-99BF-7CE91801ABC4Q36384651-DD4463F7-929E-4A1A-B9C2-CA7F0257F548Q36783335-28C5408B-F4A1-4CE5-9BAD-08F8E2ECC1FDQ37333449-EAEB7E2C-AB29-4755-A4EF-55FEEDE706D0Q38101277-9C0F6518-2076-4AA8-BDF8-144F3BF22234Q38119478-3D93BB6D-500B-41B1-A7AD-19A1AF32E3E8Q38208530-6E432DE4-651E-4510-B666-DA4F3587B848Q38235996-70169CD5-C69F-4A37-8B76-D8AD494A79EAQ38254110-A611171E-7934-49A3-9118-EEF0651EAD7DQ38547871-FE65A906-8C36-4D70-87E2-8FF135DE6CF4Q38549770-87DD2A4E-0D48-45F9-BCA3-05BC735DE567Q38559682-08558E15-2E34-4E8E-856A-D1C37860E402Q38996878-FF7A38A3-9581-4E53-91FF-58771B00CD24Q39113200-8E2F09E0-259F-49E9-B9C4-D7F09DF1757EQ39387768-0A45676A-D337-4C8A-A8EB-823DBC69333AQ40053463-4FEB29EF-4E36-413D-B8BE-FC2B26763B72Q41253896-AB358CAD-18C3-4CBA-80B5-9106215A1D3CQ41260566-38AA09D4-7AD8-4604-B6F8-447C2E1764F3Q42393162-3D11B193-DCA9-476B-8A63-3270888D61B2Q50792459-3C5ED61E-B23A-4CFB-B4AA-61FA5910BFBEQ51125785-51FECCD6-6494-4A09-A84F-5394F9D33AAEQ51461502-77852BBA-4E58-44BE-899B-38656F642A6EQ52319943-5E160D5E-1CF3-4623-B929-B0E9A0C0155BQ53652478-0C2E77CA-2DF7-4DEF-854B-A9AEEEC18587Q57839583-5C61D74E-460A-4261-85C1-DD4768E4BD2AQ58224291-C868FBDB-6EA6-46C4-844F-A0FE2B4A08EFQ58301130-8341AC4E-224A-4948-9495-16EECFECD719Q59216296-CA5D281C-78E3-40C6-906D-BE89799F502F
P2860
Noninvasive prenatal testing for aneuploidy–ready for prime time?
description
im April 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 28 February 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2012
@uk
name
Noninvasive prenatal testing for aneuploidy–ready for prime time?
@en
Noninvasive prenatal testing for aneuploidy–ready for prime time?
@nl
type
label
Noninvasive prenatal testing for aneuploidy–ready for prime time?
@en
Noninvasive prenatal testing for aneuploidy–ready for prime time?
@nl
prefLabel
Noninvasive prenatal testing for aneuploidy–ready for prime time?
@en
Noninvasive prenatal testing for aneuploidy–ready for prime time?
@nl
P2093
P1476
Noninvasive prenatal testing for aneuploidy-ready for prime time?
@en
P2093
David Wright
Helen White
Melissa Hill
P304
P356
10.1016/J.AJOG.2012.02.021
P407
P577
2012-02-28T00:00:00Z